Studles on β-Lactam Antibiotics for Medicinal Purpose. XVIII
β-ラクタム系抗生物質の薬学的研究 (第18報)

HIROSHI SADAKI, HIROYUKI IMAIZUMI, TAKIHIRO INABA, TATSUO HIRAKAWA, YOSHIHARU MUROTANI, YASUO WATANABE, SHINZABUROU MINAMI, ISAMU SAIKAWA
1986 Yakugaku zasshi  
group) with reactive derivatives of (Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetic acid. II a-1 had a wide antibacterial spectrum against Gram positive and Gram negative bacteria and showed the potent antibacterial activity, being similar to those of cefmenoxime. For the purpose of developing new oral cephalosporin, various esters (IIIa-1, IVa-m, Va-d) of IIa-1 were prepared as one form of prodrugs. Urinary recoveries of these esters in mice weremeasured. Compounds having
more » ... 2-yl or 5-chloro-1,2,4-triazol-1-yl as a substituent of3-position and pivaloyloxymethyl or 1-pivaloyloxyethyl as ester group showed high recoveries ranging
doi:10.1248/yakushi1947.106.2_129 fatcat:r5fsq4c3fzhzzg2n7ensxd4oeq